Analystreport

Regulus Therapeutics Inc (NASDAQ: RGLS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Regulus Therapeutics Inc.  (RGLS) 
Last regulus therapeutics inc. earnings: 3/12 04:37 pm Check Earnings Report
US:NASDAQ Investor Relations: regulusrx.com/investors